A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin, the first of its kind in 20 years.

Opioids are a class of drugs that “derive from, or mimic, natural substances found in the opium poppy plant”, according to ...